Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» COVID-19
COVID-19
Half Of U.S. Population Fully Vaccinated Against Covid-19, Says White House
Forbes
Sun, 08/8/21 - 12:03 am
vaccines
COVID-19
Why COVID Vaccines for Younger Kids Won't Win Authorization as Soon as Expected
Motley Fool
Fri, 08/6/21 - 11:25 am
Pfizer
BioNTech
Moderna Therapeutics
FDA
COVID-19
vaccines
pediatric
FDA could lay out a national strategy for Covid-19 booster shots in early September
CNN
Thu, 08/5/21 - 11:09 pm
FDA
Joe Biden
vaccines
boosters
COVID-19
Novavax delays Covid vaccine emergency authorization submission to FDA until fourth quarter
CNBC
Thu, 08/5/21 - 11:07 pm
Novavax
COVID-19
vaccines
FDA
Emergency Use Authorization
Is BioNTech Contradicting Pfizer About the Need for Booster Doses?
Motley Fool
Thu, 08/5/21 - 11:05 pm
Pfizer
BioNTech
vaccines
COVID-19
Albert Bourla
Ugur Sahin
boosters
Pharma CEOs
Moderna says its vaccine is 93 percent effective six months after full immunization
Washington Post, DC
Thu, 08/5/21 - 11:09 am
Moderna Therapeutics
vaccines
COVID-19
Moderna's Covid-19 vaccine sales to trail Pfizer's total significantly in 2021 and 2022
Endpoints
Thu, 08/5/21 - 10:58 am
Moderna Therapeutics
Pfizer
COVID-19
vaccines
Can mRNA vaccines do for cancer what they did with Covid-19?
MedCity News
Wed, 08/4/21 - 10:56 pm
vaccines
MRNA
cancer
COVID-19
4 Reasons Why Employee Engagement is More Important than Ever for Companies
BioSpace
Wed, 08/4/21 - 10:54 am
employees
employee engagement
pandemic
COVID-19
Boston Scientific and Stryker Get Another NTAP Year Because of COVID-19
Medical Devices and Diagnostics Industry
Wed, 08/4/21 - 10:50 am
devices
CMS
NTAP
Boston Scientific
Stryker
COVID-19
FDA aims to give full approval to Pfizer vaccine by Labor Day
The Hill
Wed, 08/4/21 - 12:06 am
Pfizer
vaccines
COVID-19
FDA
Sanofi agrees to buy U.S. mRNA partner Translate Bio in $3.2 billion deal
CNBC
Tue, 08/3/21 - 11:16 am
Sanofi
M&A
Translate Bio
vaccines
COVID-19
CytoDyn catches SEC, DOJ scrutiny over public claims about COVID-19 drug's viability
Fierce Biotech
Tue, 08/3/21 - 11:14 am
CytoDyn
FDA
COVID-19
DOJ
SEC
Eli Lilly's COVID-19 antibody sales crater as variants, vaccines take a toll
Fierce Pharma
Tue, 08/3/21 - 11:08 am
Eli Lilly
earnings
COVID-19
antibodies
Vaxart Scores IND For S-Only Oral Tablet COVID-19 Vaccine Candidate
BioSpace
Tue, 08/3/21 - 11:07 am
Vaxart
FDA
COVID-19
vaccines
oral vaccines
3 Reasons Why Pfizer's and Moderna's Vaccine Revenue Growth Is Just Getting Started
Motley Fool
Tue, 08/3/21 - 11:03 am
Pfizer
Moderna Therapeutics
vaccines
COVID-19
How the Delta Variant Could Change the World of Coronavirus Vaccine Stocks
Motley Fool
Tue, 08/3/21 - 10:59 am
vaccines
COVID-19
Delta COVID-19 variant
This Could Be Pfizer's Next COVID Blockbuster -- and It Isn't a Vaccine
Motley Fool
Tue, 08/3/21 - 10:57 am
Prizer
clinical trials
COVID-19
BNT162b2
BioNTech
Pfizer-BioNTech COVID-19 vaccine outperforms Sinovac jab in antibody study
Biopharma Reporter
Mon, 08/2/21 - 09:43 pm
Pfizer
BioNTech
Sinovac
vaccines
COVID-19
With expanded FDA nod, Regeneron's COVID-19 antibody drug can help the immunocompromised
Fierce Pharma
Mon, 08/2/21 - 10:56 am
Regeneron
FDA
COVID-19
REGEN-COV
Pages
« first
‹ previous
…
57
58
59
60
61
62
63
64
65
…
next ›
last »